Results 121 to 130 of about 6,579 (240)

Transarterial Chemoembolization vs Yttrium-90 Transarterial Radioembolization [PDF]

Gastroenterology, 2017
Lance L, Stein, Madeline C, Tully, Aravind, Arepally   +2 more
openaire   +2 more sources

Comparative Evaluation of Intraarterial Therapy Methods for Hepatocellular Cancer

Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Aim: to compare various methods of intraarterial therapy for hepatocellular carcinoma (HCC) in terms of survival, adverse events, and cost-effectiveness.Key points.
A. P. Petrosyan, V. V. Kucherov, Yu. A. Emelyanova, A. D. Kaprin, S. A. Ivanov, L. O. Petrov, N. A. Falaleeva, A. G. Isaeva, A. S. Dikova, A. T. Stekhova, E. A. Volicheva   +10 more
doaj   +1 more source

Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma

Clinical and Translational Radiation Oncology, 2019
Background: Intrahepatic cholangiocarcinoma (ICC) is a highly lethal malignancy. For patients with locally advanced, unresectable disease, numerous liver-directed therapy options exist, including chemoradiation (CRT), stereotactic body radiation therapy (
Nikhil T. Sebastian, Yubo Tan, Eric D. Miller, Terence M. Williams, Dayssy Alexandra Diaz   +4 more
doaj   +1 more source

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer [PDF]

, 2014
Liver metastases from colorectal cancer (CRC) result in substantial morbidity and mortality. The primary treatment is systemic chemotherapy, and in selected patients, surgical resection; however, for patients who are not surgical candidates and/or fail ...
Bande, Dinesh, Beg, Muhammad S., Blaszkowsky, Lawrence S., Ganguli, Suvranu, Kalva, Sanjeeva P., Pillai, Anil K., Raval, Mihir   +6 more
core   +2 more sources

The role of radiological interventions in hepatocellular carcinoma before liver transplantation: a surgical perspective

Frontiers in Surgery
Liver transplantation (LT) remains the gold standard treatment for patients with unresectable hepatocellular carcinoma (HCC) within or, in select cases, beyond the Milan criteria. However, with the increasing complexity of HCC management and the scarcity
Altan Alim, Derek DuBay
doaj   +1 more source

Liver transplantation is a preferable alternative to palliative therapy for selected patients with advanced hepatocellular carcinoma [PDF]

, 2017
Background: Patients with hepatocellular carcinoma (HCC) beyond the traditional criteria (advanced HCC) are typically offered palliation, which is associated with a 3-year survival rate lower than 30%.
A Fouly El, A Vitale, Adam C. Doyle, Aloysious D. Aravinthan, Anand Ghanekar, Assaf Issachar, Boraiah Sreeharsha, C Lance, C Sandroussi, C Toso, C Toso, CM Lo, David R. Grant, DC Mulligan, EA Pomfret, Eberhard L. Renner, European Association for the Study of the L, European Organisation for R, Treatment of C, F Rossler, FY Yao, FY Yao, FY Yao, G Moray, G Sapisochin, G Sapisochin, Gonzalo Sapisochin, HH Thein, Hla-Hla Thein, HW Lee, Ian D. McGilvray, J Bruix, J Bruix, JM Llovet, JP Roberts, KM Olthoff, LE Moreno-Luna, Leslie B. Lilly, LS Belli, M Selzner, Mamatha Bhat, Mark S. Cattral, Markus Selzner, N Mehta, Nazia Selzner, Nicolas Goldaracena, P Yang, Paul D. Greig, R Lencioni, R Lencioni, R Loomba, S Iwatsuki, S Merani, Silvio G. Bruni, T Bittermann, TM Schmitt, U Cillo, V Mazzaferro, V Mazzaferro, V Mazzaferro, V Mazzaferro, Y Zhao   +59 more
core   +2 more sources

Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patients [PDF]

, 2015
Sorafenib is an effective anti-angiogenic treatment for hepatocellular carcinoma (HCC). The assessment of tumor progression in patients treated with sorafenib is crucial to help identify potentially-resistant patients, avoiding unnecessary toxicities ...
Bargellini, Irene, Bertini, Marco, Bertoni, Michele, Bresci, Giampaolo, Federici, Graziana, Giacomelli, Luca, Marceglia, Sara, Metrangolo, Salvatore, Mismas, Valeria, Parisi, Giuseppe, Romano, Antonio, Sacco, Rodolfo, Tumino, Emanuele   +12 more
core   +1 more source

Transarterial Radioembolization: A New Selection to Treat Hepatocellular Carcinoma

International Journal of Chemistry, 2016
<p>With the development of the material science, the clinical application of stable nuclide microspheres has become a hot spot of endovascular treatment of liver cancer in last 10 years. Transarterial radioembolization came to be a new selection to treat hepatocellular carcinoma.
Haipeng Yu, Zhi Guo, Changfu Liu, Tonguo Si, Xueling Yang, Weihao Zhang, Yan Xu, Yong Li   +7 more
openaire   +1 more source

Health Outcomes and Resource Consumption Analysis of Radioembolization with Y90 Glass Microspheres (TARE-Y90) Versus Transarterial Chemoembolization with Irinotecan (DEBIRI) in Patients with Liver Metastases from Colorectal Cancer in Spain

Diagnostics
Background: The present study aims to investigate the superiority of TARE-Y90 in the treatment of liver metastases from colorectal cancer in comparison to DEBIRI and perform a parallel resource consumption study to demonstrate a possible favorable cost ...
Juan José Ciampi-Dopazo, Gonzalo Ruiz Villaverde, Juan José Espejo, Raúl García Marcos, Daniel Pérez Enguix, Serena Pisoni, José J. Martínez-Rodrigo, Pablo Navarro Vergara, Pedro Pardo Moreno, Antonio Rodríguez-Fernández   +9 more
doaj   +1 more source

Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma [PDF]

, 2015
Adeel R. Seyal, Fernanda D. Gonzalez‐Guindalini, Atilla Arslanoğlu, Carla Harmath, Robert J. Lewandowski, Riad Salem, Vahid Yaghmai   +6 more
openalex   +1 more source